Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000153990 | SCV000203615 | likely benign | not specified | 2014-06-29 | criteria provided, single submitter | clinical testing | |
Lupski Lab, |
RCV000454344 | SCV000537978 | likely pathogenic | Abnormal brain morphology | criteria provided, single submitter | research | ||
Ambry Genetics | RCV000720991 | SCV000851875 | benign | History of neurodevelopmental disorder | 2012-12-03 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000878811 | SCV001021783 | benign | not provided | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000153990 | SCV002066086 | likely benign | not specified | 2019-03-18 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000153990 | SCV004847355 | benign | not specified | 2023-10-18 | criteria provided, single submitter | clinical testing | The p.Val53Leu variant in SOX3 is classified as benign because it has been identified in 2.1% of African/African American chromosomes, including 1 homozygote, in gnomAD (http://gnomad.broadinstitute.org, v.3.1.2), which is higher than expected for a disease causing variant in SOX3. ACMG/AMP Criteria applied: BA1. |
Victorian Clinical Genetics Services, |
RCV004593993 | SCV005086758 | likely benign | Intellectual disability, X-linked, with panhypopituitarism | 2023-07-17 | criteria provided, single submitter | clinical testing | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as likely benign. Following criteria are met: 0308 - Population frequency for this variant is out of keeping with known incidence of intellectual developmental disorder, X-linked, with isolated growth hormone deficiency, with more than 300 hemizygous alleles in gnomAD v2 (MIM#300123). (SB) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign |
Diagnostic Laboratory, |
RCV000153990 | SCV001740656 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000878811 | SCV001797719 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000153990 | SCV001925375 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000878811 | SCV001932787 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000153990 | SCV001969360 | benign | not specified | no assertion criteria provided | clinical testing |